Ignite Creation Date:
2025-12-25 @ 2:04 AM
Ignite Modification Date:
2026-02-09 @ 1:53 AM
Study NCT ID:
NCT02428660
Status:
COMPLETED
Last Update Posted:
2017-02-23
First Post:
2015-04-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Drug & Gene Interaction Risk Analysis With & Without Genetic Testing Among Patients Undergoing MTM
Sponsor:
Genelex Corporation
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Cytochrome P450 CYP2D6 Enzyme Deficiency | View |
| None | Poor Metabolizer Due to Cytochrome P450 CYP2D6 Variant | View |
| None | Ultrarapid Metabolizer Due to Cytochrome P450 CYP2D6 Variant | View |
| None | Extensive Metabolizer Due to Cytochrome P450 CYP2D6 Variant | View |
| None | Cytochrome P450 CYP2C9 Enzyme Deficiency | View |
| None | Cytochrome P450 CYP2C19 Enzyme Deficiency | View |
| None | Drug Metabolism, Poor, CYP2D6-RELATED | View |
| None | Drug Metabolism, Poor, CYP2C19-RELATED | View |
| None | CYP2D6 Polymorphism | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Polypharmacy | View |
| None | Chronic conditions | View |
| None | Drug Therapy Problems | View |
| None | Medication Therapy Management | View |
| None | Medication-Related Problems | View |
| None | CYP3A4 | View |
| None | CYP3A5 | View |
| None | Drug-drug interactions | View |
| None | Drug-gene interactions | View |
| None | Drug-drug-gene interactions | View |
| None | Adverse Drug Reactions | View |
| None | Activities of Daily Living | View |